Omtryg and Rosiglitazone Maleate

• Generic Name: omega-3 polyunsaturated fatty acids
• Dosage Forms: capsule
• Other Brand Names: Divista, Fish Oil, Lovaza, MegaKrill, Nature's Bounty Red Krill Oil, Prenatal DHA, TheraTears Nutrition, Vascazen, Vayarin, Wellbaby DHA, Dry Eye Omega Benefits, Animi-3, Cardio Omega Benefits, EPA Fish Oil, Fish Oil Ultra, Flex Omega Benefits, Icar Prenatal Essential Omega-3, Marine Lipid Concentrate, MaxEPA, MaxiTears Dry Eye Formula, MaxiVision Omega-3 Formula, Mi-Omega NF, Mom's Omega Advantage, Omega Essentials, Sea-Omega, Sea-Omega 30, TherOmega, Mi-Omega, Omacor, Proepa, Super-EPA, Omega-500, Omega-3, Sea-Omega 70, Animi-3 with Vitamin D, Omega Essentials Basic, TherOmega Sport, Triple Strength Red Krill Oil, Salmon Oil, Dual Spectrum Omega-3, Disney Omega-3 Gummies, Epanova, Ovega-3 Vegetarian, Omega-3 D-3 Wellness Pack, Vayacog, Vayarin Plus, Triklo

Omega-3-acid ethyl esters are used together with a proper diet to lower very high triglyceride (fat-like substance) levels in the blood. This medicine may help prevent medical problems caused by clogged blood vessels such as heart attacks and strokes.

This medicine is available only with your doctor's prescription.

• Generic Name: rosiglitazone
• Dosage Forms: n.a.
• Other Brand Names: Avandia

Used as monotherapy or in combination with a sulfonylurea, metformin, or a sulfonylurea and metformin as an adjunct to diet and exercise for the management of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM).

May be added to glyburide/metformin fixed-combination therapy if hyperglycemia is not adequately controlled with the fixed combination.

May be used in combination with repaglinide if hyperglycemia is not adequately controlled with repaglinide monotherapy.

May use fixed combination of rosiglitazone/metformin (Avandamet) when treatment with rosiglitazone and metformin is appropriate.

May use fixed combination of rosiglitazone/glimepiride (Avandaryl) when treatment with rosiglitazone and glimepiride is appropriate.

Metformin is the preferred initial oral antidiabetic agent for patients with type 2 diabetes mellitus. Thiazolidinediones are one of several second-line agents used with other oral antidiabetic agents (e.g., metformin) in patients who are inadequately controlled on their current oral therapy. Because of potential for serious adverse effects, American Diabetes Association (ADA) recommends that clinicians carefully weigh the potential risks and benefits of thiazolidinediones versus other second-line agents (i.e., insulin, sulfonylureas).

Use in combination with insulin not recommended.

Because endogenous insulin is required for activity, not indicated for type 1 diabetes mellitus or diabetic ketoacidosis.